Benutzer: Gast  Login
Titel:

Neoadjuvant therapy in pancreatic cancer: what is the true oncological benefit?

Dokumenttyp:
Review; Journal Article; Review
Autor(en):
Ren, Lei; Mota Reyes, Carmen; Friess, Helmut; Demir, Ihsan Ekin
Abstract:
BACKGROUND: Neoadjuvant therapies (neoTx) have revolutionized the treatment of borderline resectable (BR) and locally advanced (LA) pancreatic cancer (PCa) by significantly increasing the rate of R0 resections, which remains the only curative strategy for these patients. However, there is still room for improvement of neoTx in PCa. PURPOSE: Here, we aimed to critically analyze the benefits of neoTx in LA and BR PCa and its potential use on patients with resectable PCa. We also explored the feasi...     »
Zeitschriftentitel:
Langenbecks Arch Surg
Jahr:
2020
Band / Volume:
405
Heft / Issue:
7
Seitenangaben Beitrag:
879-887
Volltext / DOI:
doi:10.1007/s00423-020-01946-4
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/32776259
Print-ISSN:
1435-2443
TUM Einrichtung:
Chirurgische Klinik und Poliklinik
 BibTeX